NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$2.33
+0.06 (+2.64%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+813.3% upside
Low Target
$14.65
Average Target
$21.28
High Target
$27.46
Current Price
$2.33
Current
$2.33
$2.33
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Scenario Analysis
Bear Case
$14.65
528.8%
Low target
Base Case
$21.28
+813.3%
Avg target
Bull Case
$27.46
+1,078.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$5.06
-53.9% from high
52-Week Low
$1.62
+43.8% from low
Target vs 52W High
$21.28
+321.0% vs high
Next Earnings Report
Nov 16, 2026
8d
until earnings
EPS Est: $-0.03
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals